FindTrial
Sign In

Severe Antibiotic-Resistant Blood Infections in ICU Patients: Who Is at Risk and What Are the Outcomes?

Risk factors and outcomes of patients with metallo-beta-lactamase-producing gram-negative bloodstream bacterial infections in ICU: a prospective observational study. - MBL risk factors

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2026/01/100500
Enrollment
600
Registered
2026-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B961- Klebsiella pneumoniae [K. pneumoniae] as the cause of diseases classified elsewhere

Interventions

Intervention1: Nil: Nil

Sponsors

Sir Gangaram Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Adult patients in intensive care unit found to have gram negative bacteria (GNB) positive blood stream infection

Exclusion criteria

Exclusion criteria: 1) Patients already enrolled in any therapeutic intervention study. 2) Patients who have a lab-confirmed bloodstream MBL infection at the time of admission to the ICU. 3) Refusal to participate in the study.

Design outcomes

Secondary

MeasureTime frame
- 28 days all-cause mortality, ICU Length of stay & incidence of blood stream infection with MBL GNB study bacteria.Timepoint:—

Primary

MeasureTime frame
Risk factors of patients having blood stream infection with Metallobetalactamases producing study pathogens.Timepoint: patients risk factors will be assessed as soon as patients blood is being withdrawn for blood cultures .—

Countries

India

Contacts

Public ContactDr. Prasoon Gupta
drprasoon.gupta85@gmail.com9891571699

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 7, 2026